Retatrutide Weight Loss Explained: How Triple-Agonist Therapy Works
Retatrutide Explained: How Triple-Agonist Weight Loss Works Retatrutide Weight Loss Explained and Why It’s Different From GLP-1s Interest in retatrutide weight loss is growing as patients and providers explore options beyond traditional GLP-1 medications. While semaglutide and tirzepatide have reshaped medical weight loss, retatrutide represents a next-generation approach to targeting obesity and metabolic dysfunction. Although retatrutide is not yet widely available, understanding how it works clarifies why it is being considered a potential shift in weight loss therapy — not simply another injectable option. Retatrutide Weight Loss Explained Retatrutide is classified as a triple-agonist medication because it targets three metabolic hormone receptors instead of one or two. Like semaglutide and tirzepatide, it activates GLP-1 receptors , which help regulate appetite and blood sugar. Additionally, retatrutide also activates GIP and glucagon receptors . This third pathway is what sets...